← Back to Search

Behavioural Intervention

Dreem + PSG for Insomnia

N/A
Waitlist Available
Research Sponsored by Dreem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Summary

This trial tests the Dreem 3 headband, which monitors sleep, on people with insomnia. It compares the headband's data to traditional sleep study methods to see if it works as well.

Eligible Conditions
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance of the automatic sleep stage scoring of the Dreem 3 System compared to the consensus of 3 independent certified sleep scorers realized on the polysomnography signal.
Secondary outcome measures
LPS (Latency to Persistent Sleep)
Respiratory Rate
SE (Sleep Efficiency)
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dreem + PSGExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dreem 3 System vs PSG
2022
N/A
~50

Find a Location

Who is running the clinical trial?

DreemLead Sponsor
6 Previous Clinical Trials
237 Total Patients Enrolled
~12 spots leftby Sep 2025